STOCK TITAN

Ekso Bionics Holdings (EKSO) Revenue by Year

EKSO NASDAQ

Ekso Bionics Holdings, Inc. generated $12.8M in revenue in fiscal year 2025. This represents a decrease of 28.6% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $11.6M in revenue. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Ekso Bionics Holdings, Inc. has filed alongside them.

FY2025 annual
Revenue $12.8M
YoY -28.6%
5Y CAGR +7.6%
10Y CAGR +4.0%

Ticker history: EKSO became CHRN (ChronoScale Holdings Corporation) on . Earlier news and filings retain their original names and dates. View EKSO history.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EKSO Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Revenue$11.6M$12.8M-28.6%$17.9M-1.9%$18.3M+41.6%$12.9M+14.8%$11.2M+26.6%$8.9M-36.2%$13.9M+22.8%$11.3M+54.1%$7.4M-48.3%$14.2M+64.2%$8.7M+62.6%$5.3M+61.3%$3.3MN/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

EKSO Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Revenue$2.1M-36.6%$3.1M-38.3%$4.2M+2.4%$2.1M-58.4%$3.4M-10.1%$5.1M+5.0%$4.1M-10.4%$5.0M+5.3%$3.8M-8.9%$4.8M+31.5%$4.6M+38.4%$4.7M+41.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Ekso Bionics Holdings, Inc. financials

Frequently Asked Questions

Ekso Bionics Holdings, Inc. generated $12.8M in revenue in fiscal year 2025.

Ekso Bionics Holdings, Inc. (EKSO) revenue fell by 28.6% year over year, from $17.9M to $12.8M in fiscal year 2025.

Ekso Bionics Holdings, Inc. (EKSO) reported $11.6M in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Ekso Bionics Holdings, Inc. (EKSO) reported $2.1M in revenue in Q1 2026. This represents a decrease of 36.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Ekso Bionics Holdings, Inc. (EKSO) reported on that line in every period on record.